Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-03-30
2011-12-20
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100
Reexamination Certificate
active
08080384
ABSTRACT:
A method for determining probability that prostate cancer will metastasize, as well as a diagnostic reagent used therefor is disclosed. It was discovered that the percentage that NF-κB-p65/RelA has the 254th amino acid threonine which is phosphorylated is significantly higher in the prostate cancer cells in the cases where the bone metastasis was observed than in the cases where bone metastasis was not observed. Thus, the method for determining probability that prostate cancer will metastasize comprises measuring human NF-κB-p65/RelA in which 254th amino acid threonine is phosphorylated, which human NF-κB-p65/RelA is contained in a prostate tissue separated from human.
REFERENCES:
patent: 2003/0073096 (2003-04-01), Bao et al.
patent: 2003/0153007 (2003-08-01), Chen et al.
patent: 2002-511564 (2002-04-01), None
patent: 2004-532390 (2004-10-01), None
patent: WO-99/42830 (1999-08-01), None
Aoki Ichiro
Ryo Akihide
Sasaki Takeshi
Birch & Stewart Kolasch & Birch, LLP
Halvorson Mark
Yokohama City University
Yu Misook
LandOfFree
Method for determination of prognosis of prostate cancer,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determination of prognosis of prostate cancer,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determination of prognosis of prostate cancer,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4270717